Fresh2 Group Limited (FRES)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Gold hits new high putting precious metals miners atop the leader board
Precious metals stocks led the FTSE 100 higher on Friday, with Endeavour Mining PLC (LSE:EDV, TSX:EDV, OTCQX:EDVMF) and Fresnillo PLC (LSE:FRES) the top risers, after gold surged to a fresh all-time high. The precious metal was trading at $3,219.93 an ounce by midday, driven by renewed investor appetite for safe-haven assets amid market turbulence triggered by US trade policy.
Why Is Fresh2 Group (FRES) Stock Up 31% Today?
Fresh2 Group (NASDAQ: FRES ) stock is heading higher on Tuesday alongside heavy pre-market trading of the biotechnology company's shares. This has more than 5.6 million shares of FRES stock changing hands as of this writing.
Fresh2 Group Limited (FRES) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Fresh2 Group Limited ever had a stock split?
Fresh2 Group Limited Profile
| Biotechnology Industry | Healthcare Sector | Haohan Xu CEO | NASDAQ (CM) Exchange | 03635R305 CUSIP |
| US Country | 75 Employees | - Last Dividend | 4 Nov 2022 Last Split | 22 May 2023 IPO Date |
Overview
Fresh2 Group Limited, initially known as AnPac Bio-Medical Science Co., Ltd., is a biotechnological entity focused on innovative health solutions. Founded in 2010 and now operating out of New York, New York, the company has made significant strides in addressing multi-cancer detection and screening through advanced cancer differentiation analysis technology. Besides its primary focus on biotechnology, Fresh2 Group Limited has diversified its operations to include an array of services suited to corporations and life insurance companies within the People's Republic of China. This company's commitment to enhancing early cancer detection capabilities illustrates a forward-thinking approach to global health issues, further extended by its additional ventures in genetic testing, skincare products, and e-commerce platforms designed to streamline food supply chains.
Products and Services
- Multi-Cancer Screening and Detection Tests
Utilizing proprietary cancer differentiation analysis technology and devices, Fresh2 Group Limited provides comprehensive cancer screening and detection services. This innovative approach is marketed primarily to corporations and life insurance companies, aiming to revolutionize early cancer detection and subsequent care.
- Physical Checkup Packages
Comprehensive physical checkup packages are another integral part of Fresh2 Group Limited’s offerings. These packages are meticulously designed to provide a holistic health assessment, offering valuable insights into an individual's health status and fostering a proactive approach to maintaining good health.
- Technology Services
The company's technology services span market research, design, coding, development, and testing. These services underscore Fresh2 Group Limited's versatile capabilities, not just in biotechnology but in crafting sophisticated technological solutions across different fields.
- Genetic Testing Kits
Fresh2 Group Limited also ventures into the personal health domain by offering genetic testing kits. These kits empower individuals with knowledge about their genetic predispositions, potentially guiding lifestyle choices and preventive health strategies.
- Skin-Care Products
In addition to its health and technology services, the company markets a line of skincare products. These products complement its health offerings, focusing on wellness and personal care from a scientific and biotechnological perspective.
- E-commerce Platform
Fresh2 Group Limited operates an innovative e-commerce platform. This platform specifically caters to the food industry, facilitating connections between food suppliers and key players in the food retail and service sectors, such as supermarket operators and restaurant owners, showcasing the company's diverse interests and capabilities.
